Unconfigured Ad

Collapse
This topic is closed.
X
X
 
  • Time
  • Show
Clear All
new posts
  • tlitman
    Junior Member
    • Jun 2008
    • 9

    #1

    Hello from Thomas

    Hi all,

    My name is I'm Thomas Litman; I run the microRNA biomarker discovery department at Exiqon, Denmark.

    We are looking for new and interesting miRNA biomarkers for cancer diagnostics, and so far, we have applied 454 and Solexa/Illumina technology for this (outsourced to service providers).

    Now, together with our collaborators at University of Copenhagen (professor Anders Krogh) and the State University Hospital (Finn Cilius Nielsen and Gedske Daugaard) we have received a grant to purchase next generation sequencing equipment. Initially, we were planning to go for the SOLiD system, because - on paper - it had the best specifications compared to 454 and Solexa. However, we have had problems obtaining a test run with our synthetic miRNA pool on the SOLiD system, so I wonder if the technology is ready yet, and whether there are other - and better - alternatives?

    What do you think?

    Should we instead go for the Polonator?

    Or perhaps even Helicos?

    Any thoughts are more than welcome.

    BTW, soon we will be looking for talented Ph.D.s / post docs to help with the data analysis ... just in case you know anybody interested

    Best regards

    - Thomas
    ([email protected])


    Thomas Litman
    Head of Biomarker Discovery
    Exiqon A/S
    Bygstubben 3
    DK-2950 Vedbaek
    DENMARK

    TEL +45 4565 0933
    MBL +45 4090 2135
    E-mail [email protected]
  • Chipper
    Senior Member
    • Mar 2008
    • 323

    #2
    Hi,

    I wouldn't hesitate to go for SOLiD from a sequence quality and throughput point of view. For the other machines I guess you will have to wait for more data to come out to be able to judge them. What sort of sequence depth do you need for your samples?

    Comment

    • tlitman
      Junior Member
      • Jun 2008
      • 9

      #3
      SOliD or Solexa?

      Thanks for the reply Chipper,

      So far, I have been happy with the depth of the 454 system (ca. 300K sequences), and the even higher of Solexa (ca. 4M seqs), so I don't think that I need more than this for now.

      With respect to data quality, I wonder why the service provider GATC in Germany have decided to give up on the SOLiD system, and instead go for another Illumina/Solexa machine?

      Perhaps the specs of the SOLiD system are so good mainly because of the algorithm (the color space decoding), rather than the actual chemistry used?

      - Thomas


      Thomas Litman
      Head of Biomarker Discovery
      Exiqon A/S
      Bygstubben 3
      DK-2950 Vedbaek
      DENMARK

      TEL +45 4565 0933
      MBL +45 4090 2135
      E-mail [email protected]

      Comment

      • Chipper
        Senior Member
        • Mar 2008
        • 323

        #4
        Hi,

        no, the color space "magic" is not in the algorithm but is an intrinsic part of the chemistry used. But of course there are errors also with the SOLiD but in the aligned reads you will likely se ~0.1% compared to ~1% for the Solexa.

        Dont know about GATC, but If they have one Solexa already I guess it makes sense to get another, the data handling and labwork will be much more efficient then.

        But why not try to get a sample run on the Helicos, they should be eager to get customers I guess...

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 11:13 AM
        0 responses
        17 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, Yesterday, 10:48 AM
        0 responses
        18 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        36 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        42 views
        0 reactions
        Last Post SEQadmin2  
        Working...